Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?

N. Vuilleumier; Grégoire Le Gal; Jean-Christophe Cornily; D. Hochstrasser; Henri Bounameaux; D. Aujesky; Marc Righini

doi:10.1111/j.1538-7836.2010.03879.x

Journal articles

Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?

N. Vuilleumier ¹ Grégoire Le Gal ^{2, 3} Jean-Christophe Cornily ⁴ D. Hochstrasser ¹ Henri Bounameaux ⁵ D. Aujesky ⁶ Marc Righini ⁵

1 DLM - Division of Laboratory Medicine

2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

3 CIC - Brest - Centre d'Investigation Clinique

4 CHRU - Cardio - Département de Cardiologie

5 MR - Service d'angiologie et d'hémostase

6 Division of General Internal Medicine

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadata

https://hal.univ-brest.fr/hal-00678688
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Tuesday, March 13, 2012 - 3:54:07 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?

Identifiers

Collections

Citation

Export

Metrics

23

Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?

Identifiers

Collections

Citation

Export

Share

Metrics

23